Navigation Links
Biovest in Medical Technology

Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma

WORCESTER, Mass.--(BUSINESS WIRE)--Jun 28, 2007 - Biovest International, Inc. (OTCBB: BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced on June 27, 2007 blinded interim data from the start of its fast-tracked pivotal Phase 3 clinical trial of BiovaxID(...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

...ient-specific anti-cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma. BiovaxID, which is being developed by Accentia's subsidiary, biovest International, Inc., (OTCBB: BVTI), is currently in a Fast-Tracked Phase 3 clinical trial. The Company is also proposing to enter Phase 3 clinical tri...

Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis

...tment strategy, the Company has acquired the majority ownership interest in biovest International, Inc. ("Biovest"), (BVTI.OB) and a royalty interest in Bioves...ndidate, BiovaxID(TM) and any other biologic products developed by Biovest. biovest is currently conducting a pivotal Phase 3 clinical trial for BiovaxID which...
Biovest in other areas

BioVest International, Inc.

Manufacturer of mammalian cells, as non-GMP or strictly cGMP predefined ... Biovest International develops personalized immunotherapies for life threatening ...

BioVest International - BiovaxID Immunotherapy

A core mission of Biovest is to use our expertise in hollow fiber to advance ... The Biovest cancer immunotherapy stems from work begun in 1986 on development of ...

BIOVEST >> INFO >> WWW.BIOVEST.IN >> optimal market penetration of the ...

To display this page you need a browser with JavaScript support. ... "BIOVEST"IN", "BIOVEST"US", "BIOVEST"ASIA" ... Welcome to BIOVEST"IN : Login Required ...

BVTI.OB: Summary for BIOVEST INTL INC - Yahoo! Finance

Get detailed information on BIOVEST INTL INC (BVTI.OB) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and ...

BVTIE Stock Quote, Biovest International Incorporated Stocks

Get BVTIE stock quotes and read Biovest International Incorporated's latest news headlines at TheStreet.com

Welcome to NCCC

Biovest Products and Services. The National Cell Culture Center ... The Center is housed in the modern Cell Culture Laboratory of Biovest International, Inc. ...
Other Tags
(Date:9/23/2014)... The University of California, Davis, and Academia Sinica, ... China (Taiwan), have entered into a collaborative agreement ... program that couples cutting-edge research with opportunities to ... new companies. , The agreement was signed Sept.12 ... research at UC Davis and President Chi-Huey Wong ...
(Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- A test used ... geographic regions where certain lung infections are more common, a ... lung cancer is through the use of what,s known as ... imaging called FDG-PET is used, according to the study authors. ... do parts of the lungs that don,t have ...
(Date:9/23/2014)... DC (PRWEB) September 23, 2014 ... care? The National Quality Forum (NQF) released ... ( http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( http://bit.ly/1tX3lzA ... rising cost of healthcare, how patients define affordability, ... consumers to get the best possible healthcare at ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- The ... unapproved prescription drugs is growing, so doctors need ... Food and Drug Administration warned Tuesday. In ... so widespread that it has launched a program ... and administrators about proper drug purchasing procedures. The ...
Breaking Medicine News(10 mins):Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Finding Affordable Care: Asking the Right Question is Key 2
(Date:9/23/2014)... gotten a lot greener thanks to a novel technique ... uses solar energy to accelerate tailings pond reclamation efforts ... a light source to treat oil sands process affected ... El-Din and James Bolton have found that using the ... just as efficiently but at a much lower cost. ...
(Date:9/23/2014)... will award funds to support the next phase of ... ways of predicting drug safety and effectiveness. Researchers will ... tissue chips and combine them into an integrated system ... body. Led by the National Center for Advancing Translational ... $17 million in 2014 with additional support over the ...
(Date:9/23/2014)... Eureka Therapeutics, Inc. announced today that the Company has ... new funding will be used to expand the Company,s ... clinical development. New investor Yuan Capital led the round, ... including Acorn Campus Ventures, Suma Venture and Harbinger Venture ... and development of fully-human antibodies engineered to mimic the ...
Breaking Biology News(10 mins):Solar energy-driven process could revolutionize oil sands tailings reclamation 2NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4
Other Contents